Overactive bladder: Symptom complex or separate entity?

Authors

  • Sender Herschorn Division of Urology, University of Toronto, and Martin Barkin Chair in Urological Research and attending urologist, Sunnybrook Health Sciences Centre, Toronto, ON

DOI:

https://doi.org/10.5489/cuaj.717

Abstract

In addition to the series of lectures summarized in the articles
on the preceding pages, the 2011 Canadian Urology
Forum also included a series of workshops intended to
help answer the question: “Does overactive bladder (OAB)
exist as a separate entity or is it a symptom complex that
may be associated with other conditions?”
In an effort to arrive at an answer to this question, the
participants were divided into groups and asked to examine
a particular subset of patients with OAB. The subsets were:
females, males, neurogenic and elderly. In each of these
workshops, the participants were asked to answer the following
questions:
• What is the most likely underlying cause?
• Are there unique phenotypes that can be identified
clinically that are linked to a common underlying
pathophysiology?
• What is the likelihood of associated disorders of the
outlet or pelvic floor?
• What are the most effective treatments?
Each of the groups then reported their answers back to
the entire group of participants, after which time they were
asked to vote on the key question. This review provides a
summary of the discussions that took place in each group
and concludes with the results of the vote.

Downloads

Download data is not yet available.

Author Biography

Sender Herschorn, Division of Urology, University of Toronto, and Martin Barkin Chair in Urological Research and attending urologist, Sunnybrook Health Sciences Centre, Toronto, ON

Downloads

How to Cite

Herschorn, S. (2013). Overactive bladder: Symptom complex or separate entity?. Canadian Urological Association Journal, 5(5-S2), S152-S154. https://doi.org/10.5489/cuaj.717

Issue

Vol. 5 No. 5-S2 (2011): October

Section

Review

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.